跳转至内容
Merck

1229001

USP

氟哌利多

United States Pharmacopeia (USP) Reference Standard

别名:

1-[1-[3-(p-Fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone

登录查看公司和协议定价

选择尺寸

250 MG
$608.00

$608.00


请联系客服了解存货情况

获取大包装报价

选择尺寸

变更视图
250 MG
$608.00

About This Item

经验公式(希尔记法):
C22H22FN3O2
CAS号:
分子量:
379.43
MDL编号:
UNSPSC代码:
41116107
PubChem化学物质编号:
NACRES:
NA.24

$608.00


请联系客服了解存货情况

获取大包装报价

等级

pharmaceutical primary standard

API类

droperidol

制造商/商品名称

USP

应用

pharmaceutical (small molecule)

包装形式

neat

储存温度

2-8°C

SMILES字符串

Fc1ccc(cc1)C(=O)CCCN2CCC(=CC2)N3C(=O)Nc4ccccc34

InChI

1S/C22H22FN3O2/c23-17-9-7-16(8-10-17)21(27)6-3-13-25-14-11-18(12-15-25)26-20-5-2-1-4-19(20)24-22(26)28/h1-2,4-5,7-11H,3,6,12-15H2,(H,24,28)

InChI key

RMEDXOLNCUSCGS-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

分析说明

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

其他说明

Sales restrictions may apply.

象形图

Exclamation mark

警示用语:

Warning

危险声明

预防措施声明

危险分类

Acute Tox. 4 Oral

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Droperidol- and ondansetron-induced life-threatening arrhythmias.
Jasmine Patel
Journal of emergency nursing: JEN : official publication of the Emergency Department Nurses Association, 39(4), 393-394 (2013-07-09)
I Henzi et al.
Canadian journal of anaesthesia = Journal canadien d'anesthesie, 47(6), 537-551 (2000-06-30)
To estimate the efficacy and harm produced by droperidol in the prevention of postoperative nausea and vomiting (PONV). Systematic search (MEDLINE, EMBASE, Cochrane library, hand-searching, bibliographies, all languages, up to May 1999) for randomised comparisons of droperidol with placebo in
Krzysztof Tracz et al.
British journal of clinical pharmacology, 79(4), 669-676 (2014-10-09)
Drugs used for postoperative nausea and vomiting prophylaxis are believed to provoke torsadogenic changes in cardiac repolarization. The aim of this study was to assess the effect of small doses of droperidol on the parameters of cardiac repolarization, including the
R A Chambers et al.
The Journal of clinical psychiatry, 60(10), 664-667 (1999-11-05)
As admission criteria to inpatient units become more focused on patient safety and behavioral instability, primary treatment often requires use of medications that need to be quick, safe, and effective for control of agitation. This article reviews the evidence that
E S Brown et al.
Clinical neuropharmacology, 21(5), 316-318 (1998-10-28)
There is little information in the literature concerning the use of droperidol in psychiatry. This article presents three cases in which extremely agitated and treatment-refractory persons with mixed mania derived benefit from droperidol administered orally. Symptomatic improvement, including decreased agitation

Questions

Reviews

No rating value

Active Filters

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门